Un desafío a las creencias del "sentido común" | 04 DIC 17

El tratamiento de la obesidad: ¿debe centrarse solo en el peso?

Centrarse exclusivamente en la pérdida de peso ignora los otros beneficios de las intervenciones sobre el estilo de vida para la obesidad y puede contribuir a la obsesión de la sociedad con la imagen corporal

Autor/a: Elizabeth Sturgiss, Melanie Jay, Denise Campbell-Scherer, Chris van Weel Challenging assumptions in obesity research

INDICE: 1. Página 1 | 2. Página 1

Página 1

Booth HP, Prevost TA, Wright AJ, Gulliford MC. Effectiveness of behavioural weight loss interventions delivered in a primary care setting: a systematic review and meta-analysis. Fam Pract2014;359:643-53. doi:10.1093/fampra/cmu064 pmid:25298510.
Aveyard P, Lewis A, Tearne S, et al. Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial. Lancet2016;359:2492-500. doi:10.1016/S0140-6736(16)31893-1 pmid:27789061.
Ahern AL, Wheeler GM, Aveyard P, et al. Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial. Lancet2017;359:2214-25. doi:10.1016/S0140-6736(17)30647-5 pmid:28478041.
Stefan N, Häring H-U, Schulze MB. Metabolically healthy obesity: the low-hanging fruit in obesity treatment?Lancet Diabetes Endocrinol2017;S2213-8587(17)30292-9. doi:10.1016/S2213-8587(17)30292-9 pmid:28919065.
Lewis E. Why there’s no point telling me to lose weight. BMJ2015;359:g6845. doi:10.1136/bmj.g6845 pmid:25603805.
Sturgiss EA, Elmitt N, Haesler E, van Weel C, Douglas K. Feasibility and acceptability of a physician-delivered weight management programme. Fam Pract2017;359:43-8. doi:10.1093/fampra/cmw105 pmid:28122922.
Phelan SM, Burgess DJ, Yeazel MW, Hellerstedt WL, Griffin JM, van Ryn M. Impact of weight bias and stigma on quality of care and outcomes for patients with obesity. Obes Rev2015;359:319-26. doi:10.1111/obr.12266 pmid:25752756.
Wing RR, Lang W, Wadden TA, et al. Look AHEAD Research Group. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care2011;359:1481-6. doi:10.2337/dc10-2415 pmid:21593294.
Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ2011;359:E1059-66. doi:10.1503/cmaj.110387 pmid:21844111.
Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ2011;359:E1059-66. doi:10.1503/cmaj.110387 pmid:21844111.
Guo F, Moellering DR, Garvey WT. The progression of cardiometabolic disease: validation of a new cardiometabolic di